Danapha Pharmaceutical JSC (HSTC:DAN) Total Operating Expense: ₫0.00 Mil (TTM As of . 20)


HSTC:DAN Danapha Pharmaceutical JSC HSTC:DAN
31 GF Score
Price ₫30,300.00
! 1 Warning Sign
View Full Analysis

What is Danapha Pharmaceutical JSC Total Operating Expense?

Danapha Pharmaceutical JSC HSTC:DAN 31 Total Operating Expense is ₫0.00 Mil as of . 20. GuruFocus rates HSTC:DAN with a GF Score™ of 31/100. The stock has 1 warning sign investors should review.

Danapha Pharmaceutical JSC's Total Operating Expense for the six months ended in . 20 was ₫0.00 Mil. Danapha Pharmaceutical JSC's Total Operating Expense for the trailing twelve months (TTM) ended in . 20 was ₫0.00 Mil.

Danapha Pharmaceutical JSC Total Operating Expense Related Terms

Danapha Pharmaceutical JSC Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Danapha Pharmaceutical JSC's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Danapha Pharmaceutical JSC Total Operating Expense Chart

Danapha Pharmaceutical JSC Annual Data
Trend
Total Operating Expense

Danapha Pharmaceutical JSC Semi-Annual Data
Total Operating Expense
HSTC:DAN
31GF Score
Danapha Pharmaceutical JSC HSTC:DAN
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Danapha Pharmaceutical JSC Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


For stock reported annually, GuruFocus uses latest annual data as the TTM data. Total Operating Expense for the trailing twelve months (TTM) ended in . 20 was ₫0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ₫0.00 Mil mean?
Danapha Pharmaceutical JSC (HSTC:DAN) has a Total Operating Expense of ₫0.00 Mil as of . 20. Total operating expense is the primary recurring expense associated with central operations. View historical data on Danapha Pharmaceutical JSC and its competitors.
Is Danapha Pharmaceutical JSC's Total Operating Expense too high?
Danapha Pharmaceutical JSC's current Total Operating Expense is ₫0.00 Mil. Overall, Danapha Pharmaceutical JSC has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Danapha Pharmaceutical JSC's Total Operating Expense compare to ZTS and UTHR?
Danapha Pharmaceutical JSC's Total Operating Expense of ₫0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Danapha Pharmaceutical JSC and its competitors. Danapha Pharmaceutical JSC's current Total Operating Expense is ₫0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Danapha Pharmaceutical JSC stock overvalued right now?
Danapha Pharmaceutical JSC (HSTC:DAN) has a current Total Operating Expense of ₫0.00 Mil. The current Total Operating Expense is ₫0.00 Mil. Danapha Pharmaceutical JSC's overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Danapha Pharmaceutical JSC (HSTC:DAN), the current Total Operating Expense is ₫0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Danapha Pharmaceutical JSC Business Description

Address 253 Dung Si Thanh Khe, Da Nang, VNM
Danapha Pharmaceutical JSC is a manufacturer of herbal medicine and specific drugs such as central nervous system, neurotonics, anti-diabetics, cardiovascular drug, gastrointestinal and heaptic biliary system with forms such as tablets, capsules, injection, sirup, balm and medicated oil.
31GF Score

Get the complete analysis for HSTC:DAN

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫30,300.00
Price